CA
NZ
UK
AU
IND
US
Key HighlightsOppenheimer Holdings (NYSE:OPY) fell 20.1 percent on October 30, 2026 asNet Incomedropped to USD 5.5 million from USD 21.7 million, a decline of about 75 percent, simple arithmetic on two reported numbers.Credit Acceptance (NASDAQ:CACC) fell 19.3 percent after a quarterly loss of USD …
Key HighlightsMondelez International (NASDAQ:MDLZ) rose 3.9 percent on October 30, 2026 as investors rotated into consumer staples, a sector that gained 1.6 percent while theNasdaqComposite lost 2.9 percent and the S&P 500 fell 1.8 percent.Colgate-Palmolive (NYSE:CL) rose 2.3 percent in the same session, one …
Morgan Stanley lists defense as often bipartisan, technology tied to AI and chips as potentially helped by policy on infrastructure and competition with China, financial services as possibly gaining from regulatory clarity, and health care exposed to tariffs and drug pricing. The Technology Select …
Physical limits keep a floor under prices. Exxon Mobil (NYSE:XOM) management has tied 2026 fuel margins to roughly 3 million barrels a day of refining capacity cut off by the closure of the Strait of Hormuz, and Houthi attacks on Saudi facilities kept risk …
A lockup is an agreement that stops early investors and insiders from selling for a set period. When it ends, a large block of stock can reach the market at once, which adds supply even if theBusinessis unchanged. The October 22 unlock covered up …
No press release or regulatory filing from the company explaining the move was identified for the period around November 2, 2026.
No company press release or filing dated between October 27 and November 2, 2026 was identified as the cause. Newly de-SPACed stocks often swing widely in early weeks because of a small public float, so the move is best read as trading-driven rather than …
Mingteng International (NASDAQ:MTEN) was down 6.25 percent to USD 0.8000 in pre-market trading on November 2, 2026. No company announcement dated November 2, 2026 was identified.
The shares remain below USD 1.00, and the move looks like a bounce in a heavily sold, low-priced biotech name rather than a response to new company disclosure.
The pre-market price sits above USD 1.00, but the determination relates to the closing bid record through October 26, 2026. The company did not report newEarningsin the notice.
Please wait processing your request...